HomeSP4P • FRA
add
Achieve Life Sciences Inc
Previous close
€4.21
Day range
€4.51 - €4.51
Year range
€1.73 - €4.51
Market cap
262.16M USD
Avg Volume
175.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.56M | 49.01% |
Net income | -12.72M | -50.31% |
Net profit margin | — | — |
Earnings per share | -0.37 | -48.00% |
EBITDA | -12.51M | -49.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.40M | -9.65% |
Total assets | 58.94M | -9.04% |
Total liabilities | 17.27M | -23.28% |
Total equity | 41.67M | — |
Shares outstanding | 51.10M | — |
Price to book | 5.01 | — |
Return on assets | -72.79% | — |
Return on capital | -87.40% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -12.72M | -50.31% |
Cash from operations | -9.07M | -84.29% |
Cash from investing | 6.70M | 114.39% |
Cash from financing | 41.22M | 27,042.48% |
Net change in cash | 38.86M | 175.24% |
Free cash flow | -3.37M | -25.86% |
About
Founded
1991
Headquarters
Website
Employees
25
